Lambay, Cutiefay S.
HRN: 20-66-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
CEFUROXIME 1.5GM (VIAL)
01/21/2023
01/27/2023
IV
1.5g
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice